BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33676443)

  • 1. The importance of evaluating specific myeloid malignancies in epidemiological studies of environmental carcinogens.
    Mundt KA; Dell LD; Boffetta P; Beckett EM; Lynch HN; Desai VJ; Lin CK; Thompson WJ
    BMC Cancer; 2021 Mar; 21(1):227. PubMed ID: 33676443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-acquired infections and their association with myeloid malignancies.
    Titmarsh GJ; McMullin MF; McShane CM; Clarke M; Engels EA; Anderson LA
    Cancer Epidemiol; 2014 Feb; 38(1):56-61. PubMed ID: 24275260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, survival and prevalence of myeloid malignancies in Europe.
    Visser O; Trama A; MaynadiƩ M; Stiller C; Marcos-Gragera R; De Angelis R; Mallone S; Tereanu C; Allemani C; Ricardi U; Schouten HC;
    Eur J Cancer; 2012 Nov; 48(17):3257-66. PubMed ID: 22770878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis.
    Schnatter AR; Glass DC; Tang G; Irons RD; Rushton L
    J Natl Cancer Inst; 2012 Nov; 104(22):1724-37. PubMed ID: 23111193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal B-lymphoblasts in myelodysplastic syndromes and myeloproliferative neoplasms other than chronic myeloid leukemia.
    Chan A; Kumar P; Gao Q; Baik J; Sigler A; Londono D; Liu Y; Arcila ME; Dogan A; Zhang Y; Roshal M; Xiao W
    Cytometry B Clin Cytom; 2023 May; 104(3):243-252. PubMed ID: 34897961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12.
    Srour SA; Devesa SS; Morton LM; Check DP; Curtis RE; Linet MS; Dores GM
    Br J Haematol; 2016 Aug; 174(3):382-96. PubMed ID: 27061824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of myeloid malignancies in patients with autoimmune conditions.
    Anderson LA; Pfeiffer RM; Landgren O; Gadalla S; Berndt SI; Engels EA
    Br J Cancer; 2009 Mar; 100(5):822-8. PubMed ID: 19259097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France).
    MaynadiƩ M; Girodon F; Manivet-Janoray I; Mounier M; Mugneret F; Bailly F; Favre B; Caillot D; Petrella T; Flesch M; Carli PM
    Haematologica; 2011 Jan; 96(1):55-61. PubMed ID: 20971817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms.
    Vardiman JW
    Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a myelodysplastic/myeloproliferative neoplasm-unclassifiable in a patient with acute myeloid leukemia: a case report and literature review.
    Zhao M; Sun J; Liu S; Fan H; Fu Y; Tan Y; Gao S
    J Int Med Res; 2021 May; 49(5):3000605211018426. PubMed ID: 34057843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.
    Poynter JN; Richardson M; Roesler M; Blair CK; Hirsch B; Nguyen P; Cioc A; Cerhan JR; Warlick E
    Int J Cancer; 2017 Jan; 140(1):23-33. PubMed ID: 27603749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.
    Wang SA; Hasserjian RP; Fox PS; Rogers HJ; Geyer JT; Chabot-Richards D; Weinzierl E; Hatem J; Jaso J; Kanagal-Shamanna R; Stingo FC; Patel KP; Mehrotra M; Bueso-Ramos C; Young KH; Dinardo CD; Verstovsek S; Tiu RV; Bagg A; Hsi ED; Arber DA; Foucar K; Luthra R; Orazi A
    Blood; 2014 Apr; 123(17):2645-51. PubMed ID: 24627528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Many faces of SF3B1-mutated myeloid neoplasms: concurrent mutational profiles contribute to the diverse clinical and morphologic features.
    Aqil B; Sukhanova M; Behdad A; Jennings L; Lu X; Chen Q; Chen YH; Gao J
    Hum Pathol; 2022 Nov; 129():81-89. PubMed ID: 36087739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of myeloid malignancies by subtype in Hong Kong and comparisons with Asian and white men and women in the United States.
    Bassig BA; Hu W; Morton LM; Ji BT; Xu J; Linet MS; Kwong YL; Rothman N; Wong KF; Lan Q
    Leuk Lymphoma; 2022 Aug; 63(8):1917-1924. PubMed ID: 35412943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy-related myeloid neoplasms resembling juvenile myelomonocytic leukemia: a case series and review of the literature.
    Wintering A; Smith S; Fuh B; Rangaswami A; Dahl G; Chien M; Gruber TA; Dang J; Li LS; Lenzen A; Savelli S; Dvorak CC; Agrawal AK; Stieglitz E
    Pediatr Blood Cancer; 2022 May; 69(5):e29499. PubMed ID: 34939322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN).
    Smith BN; Savona M; Komrokji RS
    Clin Lymphoma Myeloma Leuk; 2019 Jan; 19(1):1-8. PubMed ID: 30555034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders - Epidemiological Features and Overview.
    Kuendgen A; Kasprzak A; Germing U
    Front Oncol; 2021; 11():778741. PubMed ID: 34869027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EAHP 2020 workshop proceedings, pediatric myeloid neoplasms.
    Leguit RJ; Orazi A; Kucine N; Kvasnicka HM; Gianelli U; Arber DA; Porwit A; Ponzoni M
    Virchows Arch; 2022 Oct; 481(4):621-646. PubMed ID: 35819517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary acute myeloid leukemia and de novo acute myeloid leukemia with myelodysplasia-related changes - close or complete strangers?
    Jagurinoski M; Davidkova Y; Stojcov-Jagurinoska M; Balatzenko G; Spassov B; Guenova M
    Folia Med (Plovdiv); 2023 Oct; 65(5):728-736. PubMed ID: 38351754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.